BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15067344)

  • 1. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
    Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
    Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH; Chang HC; Hung WC
    J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
    Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
    FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells.
    Hara T; Matsumura-Arioka Y; Ohtani K; Nakamura M
    Cancer Sci; 2008 Jun; 99(6):1155-63. PubMed ID: 18422743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
    Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
    Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of telomerase activity in malignant glioma cells by p27KIP1.
    Kanzawa T; Komata T; Kyo S; Germano IM; Kondo Y; Kondo S
    Int J Oncol; 2003 Dec; 23(6):1703-8. PubMed ID: 14612944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
    Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
    Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.
    Kitagawa Y; Kyo S; Takakura M; Kanaya T; Koshida K; Namiki M; Inoue M
    Clin Cancer Res; 2000 Jul; 6(7):2868-75. PubMed ID: 10914736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase.
    Kim H; Farris J; Christman SA; Kong BW; Foster LK; O'Grady SM; Foster DN
    Biochem J; 2002 Aug; 365(Pt 3):765-72. PubMed ID: 11978176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.